We are live on ! Find out more
CIS

Capital International Sarl Portfolio holdings

AUM $6.11B
1-Year Est. Return 32.29%
This Fund
S&P 500
This Quarter Est. Return
+26.76%
1 Year Est. Return
+32.29%
3 Year Est. Return
+120.6%
5 Year Est. Return
+165.23%
10 Year Est. Return
+684.77%
AUM
$752M
AUM Growth
+$203M
Cap. Flow
+$69.1M
Cap. Flow %
9.19%
Top 10 Hldgs %
24.27%
Holding
249
New
20
Increased
142
Reduced
34
Closed
44

Top Buys

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$12.3M
2
BAP icon
Credicorp
BAP
+$6.47M
3
MRK icon
Merck
MRK
+$5.41M
4
AME icon
Ametek
AME
+$4.68M
5
TRP icon
TC Energy
TRP
+$4.32M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$16M
2
ENIA
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
+$4.1M
3
ENB icon
Enbridge
ENB
+$4.04M
4
MELI icon
Mercado Libre
MELI
+$3.44M
5
AZN icon
AstraZeneca
AZN
+$2.81M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Healthcare 20.01%
3 Financials 14.67%
4 Communication Services 9.71%
5 Consumer Discretionary 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDK
151
DELISTED
CDK Global, Inc.
CDK
$829K 0.11%
20,014
+5,937
+42% +$229K
STT icon
152
State Street
STT
$51.2B
$791K 0.11%
12,451
+896
+8% +$54.1K
KT icon
153
KT
KT
$8.7B
$766K 0.1%
+78,635
New +$750K
ON icon
154
ON Semiconductor
ON
$31.6B
$732K 0.1%
36,913
+3,285
+10% +$53.5K
BHVN
155
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$712K 0.09%
9,739
– –
CI icon
156
Cigna
CI
$74.8B
$684K 0.09%
3,646
+64
+2% +$12.1K
PODD icon
157
Insulet
PODD
$9.87B
$632K 0.08%
3,251
+1,239
+62% +$237K
TEVA icon
158
Teva Pharmaceuticals
TEVA
$41B
$628K 0.08%
50,949
+38,749
+318% +$438K
AU icon
159
AngloGold Ashanti
AU
$47.2B
$611K 0.08%
+20,712
New +$512K
CE icon
160
Celanese
CE
$4.81B
$607K 0.08%
7,027
+5,237
+293% +$436K
BAC icon
161
Bank of America
BAC
$445B
$603K 0.08%
25,381
+19,866
+360% +$469K
ADSK icon
162
Autodesk
ADSK
$53B
$602K 0.08%
2,518
+516
+26% +$101K
SIVB
163
DELISTED
SVB Financial Group
SIVB
$599K 0.08%
2,781
+216
+8% +$41.6K
CNI icon
164
Canadian National Railway
CNI
$76.6B
$596K 0.08%
6,761
+2,361
+54% +$196K
PFE icon
165
Pfizer
PFE
$152B
$593K 0.08%
19,119
+5,586
+41% +$190K
BX icon
166
Blackstone
BX
$110B
$592K 0.08%
10,457
-4,195
-29% -$221K
WPM icon
167
Wheaton Precious Metals
WPM
$59.2B
$574K 0.08%
13,096
+8,597
+191% +$338K
IDXX icon
168
Idexx Laboratories
IDXX
$46.1B
$562K 0.07%
1,702
+502
+42% +$145K
SMAR
169
DELISTED
Smartsheet Inc.
SMAR
$560K 0.07%
10,998
+4,253
+63% +$216K
TRN icon
170
Trinity Industries
TRN
$2.33B
$554K 0.07%
+26,000
New +$500K
KHC icon
171
Kraft Heinz
KHC
$29.9B
$549K 0.07%
+17,200
New +$516K
MU icon
172
Micron Technology
MU
$992B
$542K 0.07%
10,511
+1,461
+16% +$68.9K
EFX icon
173
Equifax
EFX
$21.4B
$528K 0.07%
3,072
-17,713
-85% -$2.62M
HGV icon
174
Hilton Grand Vacations
HGV
$3.44B
$513K 0.07%
26,222
+6,220
+31% +$123K
BRK.B icon
175
Berkshire Hathaway Class B
BRK.B
$1.16T
$508K 0.07%
2,848
+554
+24% +$101K
5 6
7
8 9

Similar funds

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Capital International Sarl's Q2 2020 Portfolio in Review

As of Q2 2020, Capital International Sarl held 249 positions worth $752M, up 37% from $549M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital International Sarl deployed $69.1M of net new capital in Q2 2020, opening 20 new positions and adding to 142 existing holdings. Its largest new stake was Legend Biotech: 315,510 shares worth $13.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Enbridge, an estimated $4.04M trimmed.

  • Capital International Sarl's largest Q2 2020 buy was Legend Biotech: 315,510 shares worth $13.4M.
  • Capital International Sarl added most to Merck in Q2 2020, an estimated $5.41M increase.
  • Capital International Sarl's biggest Q2 2020 reduction was Enbridge, cutting an estimated $4.04M.
  • Capital International Sarl fully exited Alibaba in Q2 2020, selling an estimated $16M.
  • Capital International Sarl's ten largest holdings make up 24% of its $752M portfolio in Q2 2020.
  • Capital International Sarl opened 20 new positions and closed 44 in Q2 2020.
  • Capital International Sarl's portfolio value rose 37% quarter-over-quarter to $752M.

Based on Capital International Sarl's 13F filing for Q2 2020, filed 14 Aug 2020.